Selective serotonin reuptake inhibitors vs placebo
Frequency of attacks Per week (over 2 weeks) · primary Raynaud's phenomenon
1 finding from 1 review
- no estimate extracted1 study · 41 participantsVery low
Findings
What do systematic reviews say?
6 questions · 6 findings · 1 reviews · Vascular
No studies found 2 · 33.3%GRADE not reported 0 · 0%Very low 4 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Selective serotonin reuptake inhibitors vs placebo
Severity of attacks · primary Raynaud's phenomenon
1 finding from 1 review
- no estimate extracted1 study · 41 participantsVery low
Selective serotonin reuptake inhibitors vs placebo
Duration of attacks per day (minutes) · primary Raynaud's phenomenon
1 finding from 1 review
- no estimate extracted1 study · 41 participantsVery low
Selective serotonin reuptake inhibitors vs placebo
QoL · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Selective serotonin reuptake inhibitors vs placebo
Proportion of participants with adverse effects ‐ measured over 8 weeks · primary Raynaud's phenomenon
It is very uncertain whether selective serotonin reuptake inhibitors changes adverse events (over 4 weeks) compared with placebo (very low certainty).
1 finding from 1 review
- RR 1.54 [0.89, 2.66]1 study · 41 participantsVery low
Selective serotonin reuptake inhibitors vs placebo
RCS · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found